NCT06078670 2023-10-12
PARP Inhibitor CVL218 in Combination Therapy for Patients With Advanced Solid Tumors
Fujian Cancer Hospital
Phase 1/2 Not yet recruiting
Fujian Cancer Hospital
National Cancer Center, Korea
National Cancer Center, Korea
Hillel Yaffe Medical Center